{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:14:08Z","timestamp":1793459648669,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,8,2]],"date-time":"2008-08-02T00:00:00Z","timestamp":1217635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s12185-008-0144-x","type":"journal-article","created":{"date-parts":[[2008,7,31]],"date-time":"2008-07-31T22:46:00Z","timestamp":1217544360000},"page":"304-310","source":"Crossref","is-referenced-by-count":12,"title":["Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV"],"prefix":"10.1007","volume":"88","author":[{"given":"Shinobu","family":"Tatsunami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Mimaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shirahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Zelinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Horov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugo","family":"Hanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,2]]},"reference":[{"key":"144_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJM198910263211701","volume":"321","author":"JJ Goedert","year":"1989","unstructured":"Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989;321:1141\u20138.","journal-title":"N Engl J Med"},{"key":"144_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/00002030-199307000-00011","volume":"7","author":"AN Phillips","year":"1993","unstructured":"Phillips AN, Sabin CA, Elford J, Bofill M, Lee CA, Janossy G. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8\u00a0years of follow-up. AIDS. 1993;7:975\u201380.","journal-title":"AIDS"},{"key":"144_CR3","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/(SICI)1097-0258(19961130)15:22<2459::AID-SIM464>3.0.CO;2-Q","volume":"15","author":"A Mu\u00f1oz","year":"1996","unstructured":"Mu\u00f1oz A, Xu J. Models for the incubation of AIDS and variations according to age and period. Stat Med. 1996;15:2459\u201373.","journal-title":"Stat Med"},{"key":"144_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","volume":"368","author":"V Simon","year":"2006","unstructured":"Simon V, Ho DD, Karim QA. HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368:489\u2013504.","journal-title":"Lancet"},{"key":"144_CR5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1097\/01.aids.0000189864.90053.22","volume":"19","author":"MF Schneider","year":"2005","unstructured":"Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984\u20132004. AIDS. 2005;19:2009\u201318.","journal-title":"AIDS"},{"key":"144_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jhep.2004.11.017","volume":"42","author":"JR Kramer","year":"2005","unstructured":"Kramer JR, Giordano TP, Souchek J, El-Serag HB. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol. 2005;42:309\u201314.","journal-title":"J Hepatol"},{"key":"144_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.aids.0000198087.47454.e1","volume":"20","author":"N Merchante","year":"2006","unstructured":"Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, Torre-Cisneros J, Garcia-Garcia JA, Arizcorreta A, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS. 2006;20:49\u201357.","journal-title":"AIDS"},{"key":"144_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1351-8216.2003.00828.x","volume":"10","author":"JT Wilde","year":"2004","unstructured":"Wilde JT. HIV and HCV coinfection in heamophilia. Haemophilia. 2004;10:1\u20138.","journal-title":"Haemophilia"},{"key":"144_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1182\/blood-2005-11-4407","volume":"108","author":"DM Arnold","year":"2006","unstructured":"Arnold DM, Julian JA, Walker IR. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21\u00a0years of follow-up. Blood. 2006;108:460\u20134.","journal-title":"Blood"},{"key":"144_CR10","unstructured":"Data on File. Japanese Ministry of Health, Labour and Welfare, 2007."},{"key":"144_CR11","unstructured":"Japanese Foundation for AIDS Prevention. Official Report of National Surveillance on Coagulation Disorders in Japan 2006. Published by Japanese Foundation for AIDS Prevention, Tokyo."},{"issue":"Suppl 2","key":"144_CR12","first-page":"127","volume":"23","author":"K Yamada","year":"1992","unstructured":"Yamada K. Pathological status and therapy of HIV-infected hemophiliacs in Japan. Southeast Asian J Trop Med Public Health. 1992;23(Suppl 2):127\u201330.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"144_CR13","first-page":"550","volume":"40","author":"K Fukutake","year":"1999","unstructured":"Fukutake K, Ueda Y, Tatsunami S, Ajisawa A, Oka S, Takamatsu J, et al. Causes of death (1983\u20131997) in patients infected with Human Immunodeficiency Virus by contaminated blood coagulation factor products: report of the clinical study group on prevention and treatments of HIV infection. Jpn J Clin Hematol. 1999;40:550\u20135.","journal-title":"Jpn J Clin Hematol"},{"key":"144_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF02982611","volume":"77","author":"S Tatsunami","year":"2003","unstructured":"Tatsunami S, Taki M, Shirahata A, Mimaya J, Yamada K. The number of people in Japan with coagulation disorders: 2001 update. Int J Hematol. 2003;77:96\u20138.","journal-title":"Int J Hematol"},{"key":"144_CR15","volume-title":"Survival analysis. Techniques for censored and truncated data","author":"JP Klein","year":"1997","unstructured":"Klein JP, Moeschberger ML. Survival analysis. Techniques for censored and truncated data. New York: Springer; 1997."},{"key":"144_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00180-007-0020-9","volume":"22","author":"I Horov\u00e1","year":"2007","unstructured":"Horov\u00e1 I, Zelinka J. Contribution to the bandwidth choice for kernel density estimates. Comp Stat. 2007;22:31\u201347.","journal-title":"Comp Stat"},{"key":"144_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonzales FL, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975\u201382.","journal-title":"N Engl J Med"},{"key":"144_CR18","first-page":"256","volume":"72","author":"S Tatsunami","year":"2000","unstructured":"Tatsunami S, Fukutake K, Taki M, Shirahata A, Mimaya J, Takamatsu J, et al. Observed decline in the rate of death among Japanese hemophiliacs infected with HIV-1. Int J Hematol. 2000;72:256\u20137.","journal-title":"Int J Hematol"},{"key":"144_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/00002030-199610090-00005","volume":"10","author":"SA Strathdee","year":"1996","unstructured":"Strathdee SA, Veugelers PJ, Page-Shafer KA, McNulty A, Moss AR, Schechter MT, et al. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS. 1996;10:959\u201365.","journal-title":"AIDS"},{"key":"144_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2516.2003.00804.x","volume":"9","author":"M Quintana","year":"2003","unstructured":"Quintana M, Del Amo J, Barrasa A, Perez-hoyos S, Ferreros I, Hern\u00e1ndez F, et al. Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20\u00a0years. Haemophilia. 2003;9:605\u201312.","journal-title":"Haemophilia"},{"key":"144_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/bmj.38604.468785.DE","volume":"331","author":"CA Sabin","year":"2005","unstructured":"Sabin CA, Phillips AN, Yee TT, Griffioen A, Lee CA. Twenty-five years of HIV infection in haemophilic men in Britain: an observational study. BMJ. 2005;331:997\u20138.","journal-title":"BMJ"},{"key":"144_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0168-9525(98)01567-4","volume":"14","author":"SL Rowland-Jones","year":"1998","unstructured":"Rowland-Jones SL. Survival with HIV infection: good luck or good breeding? TIG. 1998;14:343\u20135.","journal-title":"TIG"},{"key":"144_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1532\/IJH97.06100","volume":"84","author":"T Shioda","year":"2006","unstructured":"Shioda T, Nayayama EE. Human genetic polymorphisms affecting HIV-1 diseases. Int J Hematol. 2006;84:12\u20137.","journal-title":"Int J Hematol"},{"key":"144_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.277.5328.959","volume":"277","author":"MW Smith","year":"1997","unstructured":"Smith MW, Dean M, Carrington M, Winkler C, Huttelry GA, Lomb DA, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science. 1997;277:959\u201365.","journal-title":"Science"},{"key":"144_CR25","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1073\/pnas.96.8.4581","volume":"96","author":"H Liu","year":"1999","unstructured":"Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA. 1999;96:4581\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"144_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1086\/339825","volume":"185","author":"EE Nakayama","year":"2002","unstructured":"Nakayama EE. Protective effect of interleukin-4-589T polymorphism on Human Immunodeficiency Virus type 1 disease progression: Relationship with virus load. J Infect Dis. 2002;185:1183\u20136.","journal-title":"J Infect Dis"},{"key":"144_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/BF02986625","volume":"77","author":"M Taki","year":"2003","unstructured":"Taki M, Tatsunami S, Shirahata A, Fukutake K, Mimaya J, Yamada K. Prevalence of hepatitis C virus infection in coagulation disorders in Japan. Int J Hematol. 2003;77:528\u20139.","journal-title":"Int J Hematol"},{"key":"144_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1046\/j.1365-2516.2002.00620.x","volume":"8","author":"C Lee","year":"2002","unstructured":"Lee C, Dusheiko G. The natural history and antiviral treatment of hepatitis C in haemophilia. Haemophilia. 2002;8:322\u20139.","journal-title":"Haemophilia"},{"key":"144_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0140-6736(97)05413-5","volume":"350","author":"SC Darby","year":"1997","unstructured":"Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet. 1997;350:1425\u201331.","journal-title":"Lancet"},{"key":"144_CR30","unstructured":"Japanese Foundation for AIDS Prevention. Official Report of National Surveillance on Coagulation Disorders in Japan 2004. Published by Japanese Foundation for AIDS Prevention, Tokyo."},{"key":"144_CR31","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1097\/01.aids.0000192086.64432.e7","volume":"19","author":"N Kontorinis","year":"2005","unstructured":"Kontorinis N, Agarwal K, Dieterich DT. Treatment of hepatitis C virus in HIV patients: a review. AIDS. 2005;19:S166\u201373.","journal-title":"AIDS"},{"key":"144_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/QAD.0b013e32805e8742","volume":"21","author":"C Mendoza De","year":"2007","unstructured":"De Mendoza C, Martin-Carbonero L, Barreiro P, de Baar M, Zahonero N, Rodriguez-Novoa S, et al. Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy. AIDS. 2007;21:583\u20138.","journal-title":"AIDS"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0144-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0144-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0144-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0144-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:57:04Z","timestamp":1559437024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0144-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,2]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["144"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0144-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,2]]}}}